Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer
Clinical trial NCT05553522 · TERMINATED
Trial details
- NCT number
- NCT05553522
- Sponsor
- Baptist Health South Florida
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2025-12-17
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.